Where does Longeviti Neuro Solutions, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Longeviti Neuro Solutions, Inc. ranks #18,860 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Longeviti Neuro Solutions, Inc. hold?

Longeviti Neuro Solutions, Inc. holds 15 US utility patents granted between 2020 and 2025, spanning 6 technology areas.

What is Longeviti Neuro Solutions, Inc.'s Innovation Score?

Longeviti Neuro Solutions, Inc. has an Innovation Score of 48.6 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Longeviti Neuro Solutions, Inc. focus on?

Longeviti Neuro Solutions, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Longeviti Neuro Solutions, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Longeviti Neuro Solutions, Inc..

What does claim depth mean for Longeviti Neuro Solutions, Inc.'s patents?

Longeviti Neuro Solutions, Inc.'s patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Longeviti Neuro Solutions, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Longeviti Neuro Solutions, Inc.

USPTO PatentsView assignee record - 15 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Longeviti ranks #18,860 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 6 technology areas.

#18,860
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.6/100): 17.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R18860 · US Corporation #18,860 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 15 grants
MID-PACK #18,860/49,997
PHOTO-FINISH Lambda Nu Technology
CPC-NARROW A61B · 6 areas
INNOV-PAR 48.6/100
CLAIMS-RICH 17.3 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Lambda Nu Technology LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Longeviti’s 48.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (20%) Velocity 20.0 pts (41%) Breadth 8.7 pts (18%) Claim depth 10.4 pts (21%)

Qualcomm Incorporated · highest

85
Liebherr-components… · near

49
High SEC Labs · near

49
Inno-Sports · near

49
Longeviti Neuro… · this assignee

49
Universita' Degli… · near

49
3D Lighting… · lowest

7

What this shows Longeviti's Innovation Score is 48.6/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Longeviti?

Each dot is one of Longeviti’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Longeviti’s own 17.3 claims/patent is ABOVE the 9.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Longeviti vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Longeviti's grants concentrate

Longeviti Neuro Solutions, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 73.3% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2020. By volume, Longeviti sits between Loadhog Limited and Lambda Nu Technology LLC.

Longeviti's three-year grant acceleration

Longeviti Neuro Solutions, Inc. shows 10 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Loadhog

15
Locinox

15
Lock & Lock

15
Lockdowel

15
Lotte

15
Lvmh Fragrance Br…

15
LY

15
Lambda Nu Technol…

15
Longeviti Neuro S… ◀

15

What this shows Longeviti holds 15 patents at rank #18,842, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Longeviti

By rank, the assignees closest to #18,842 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Longeviti's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Longeviti, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Longeviti ranks #1,592 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (49 here).

High SEC Labs Ltd. 49 Inno-Sports Co., Ltd. 49 Liebherr-components Deggendorf GMBH 49 Universita' Degli Studi DI Milano - Bicocca 49

Longeviti's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Longeviti Neuro Solutions, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	6.7%
2021	2	13.3%
2022	5	33.3%
2023	2	13.3%
2024	3	20.0%
2025partial year	2	13.3%

Which technologies does Longeviti Neuro Solutions, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 9

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 3

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Longeviti Neuro Solutions, Inc.'s patent record in context - here's where to go next.

Longeviti Neuro Solutions, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 73.3% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #18,860 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Longeviti Neuro Solutions, Inc. against Loadhog Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.